39 results
20-F/A
2023 FY
CYTO
Altamira Therapeutics Ltd
22 Apr 24
Annual report (foreign) (amended)
4:31pm
Report. The Company did not maintain controls to execute the criteria established in the COSO Framework for the control environment, risk assessment … Financial Reporting
The Company did not maintain controls to execute the criteria established in the COSO Framework for the control environment, risk
6-K
EX-1.1
CYTO
Altamira Therapeutics Ltd
19 Jan 24
Report of Foreign Private Issuer
4:45pm
or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges … ”) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling
6-K
EX-10.1
CYTO
Altamira Therapeutics Ltd
11 Jul 23
Altamira Therapeutics Announces Pricing of $5.0 Million Public Offering
8:32am
of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating … , “Hazardous Materials”) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal
F-1/A
EX-10.44
CYTO
Altamira Therapeutics Ltd
3 Jul 23
Registration statement (foreign) (amended)
7:09pm
with all federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air … of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise
6-K
EX-10.1
9y57pu94
5 Dec 22
Report of Foreign Private Issuer
4:30pm
6-K
EX-10.1
fb0f6zbvax7x qz
3 Dec 20
Auris Medical Holding LTD. Prices $8,000,000 Common Shares Offering Priced At-the-market
5:26pm
6-K
EX-10.1
j8nevbx bs1e1671
23 Apr 20
Report of Foreign Private Issuer
4:38pm
6-K
EX-1.1
l0vvka lpf
16 May 19
Report of Foreign Private Issuer
7:26am
F-1/A
EX-1.1
q7yw3r tkq
10 May 19
Registration statement (foreign) (amended)
3:18pm
F-1/A
EX-1.1
4m6445 3e2lli4
6 May 19
Registration statement (foreign) (amended)
5:26pm
424B3
rans0gb
20 Feb 19
Prospectus supplement
5:01pm
424B3
f7ebl tbi30ia
15 Feb 19
Prospectus supplement
4:31pm
F-1/A
9ffrgdu
13 Feb 19
Registration statement (foreign) (amended)
5:21pm
F-4/A
5clkh9gd
13 Feb 19
Registration of securities (foreign) (amended)
5:02pm